At present, dry AMD is incurable, but the treatment of wet AMD patients with intravitreal injections of antibodies or fusion proteins effective against VEGFA and its receptor has become the golden standard and has significantly improved the outcomes of AMD therapy [23]. The gene discussed is VEGFA; the disease is age-related macular degeneration.